Consistently, treatment with metformin, a type 2 diabetes drug that elevates AMPK activity, enhanced TRIC and LSR expression in both undifferentiated and differentiated cochlear cells. This evidence concerns the gene MARVELD2 and type 2 diabetes mellitus.